TRUE Private Wealth Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$351K Buy
+5,080
New +$351K 0.04% 187
2024
Q3
Sell
-5,819
Closed -$831K 261
2024
Q2
$831K Buy
5,819
+171
+3% +$24.4K 0.09% 112
2024
Q1
$725K Buy
5,648
+79
+1% +$10.1K 0.08% 125
2023
Q4
$576K Buy
5,569
+2,516
+82% +$260K 0.07% 140
2023
Q3
$278K Buy
3,053
+165
+6% +$15K 0.04% 208
2023
Q2
$234K Buy
2,888
+80
+3% +$6.47K 0.03% 209
2023
Q1
$223K Buy
+2,808
New +$223K 0.03% 205
2022
Q4
Sell
-4,530
Closed -$225K 232
2022
Q3
$225K Buy
4,530
+128
+3% +$6.36K 0.03% 189
2022
Q2
$245K Hold
4,402
0.04% 190
2022
Q1
$250K Sell
4,402
-256
-5% -$14.5K 0.04% 206
2021
Q4
$260K Sell
4,658
-922
-17% -$51.5K 0.04% 218
2021
Q3
$267K Sell
5,580
-208
-4% -$9.95K 0.04% 199
2021
Q2
$242K Sell
5,788
-3,954
-41% -$165K 0.04% 203
2021
Q1
$333K Buy
9,742
+9,262
+1,930% +$317K 0.05% 163
2020
Q4
$16K Buy
+480
New +$16K ﹤0.01% 477
2020
Q1
Sell
-5,920
Closed -$171K 780
2019
Q4
$171K Buy
+5,920
New +$171K 0.03% 237
2019
Q3
Sell
-5,130
Closed -$130K 559
2019
Q2
$130K Buy
+5,130
New +$130K 0.02% 238
2019
Q1
Sell
-10,750
Closed -$247K 236
2018
Q4
$247K Hold
10,750
0.04% 201
2018
Q3
$253K Hold
10,750
0.04% 235
2018
Q2
$247K Buy
10,750
+1,538
+17% +$35.3K 0.04% 237
2018
Q1
$229K Sell
9,212
-3,000
-25% -$74.6K 0.04% 209
2017
Q4
$327K Buy
+12,212
New +$327K 0.06% 175